Janany S
LightNews LightNews
banner
glomerican.bsky.social
Janany S
@glomerican.bsky.social
360 followers 550 following 14 posts
Assistant Professor of Medicine, UofR
Nephrologist by Day / Muggle by night
Posts Replies Media Videos
Reposted by Janany S
nephjc.bsky.social
Tonite 11/18/25 on #Bluesky 9pm EST
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙‍♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
www.nephjc.com
November 18, 2025 at 12:29 PM
Reposted by Janany S
ajpcardio.bsky.social
🚨 New study alert: The American Heart Association’s latest “Cardiovascular-Kidney-Metabolic Syndrome” (CKM) metrics reveal major implications for life expectancy in U.S. adults. Dive into the full life-table analysis 👉 https://ow.ly/MtOT50XkE9P
#CardioSky #MedSky
October 30, 2025 at 9:35 PM
Reposted by Janany S
nephjc.bsky.social
The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky

✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social

www.nephjc.com/news/igan-kd...
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
www.nephjc.com
October 28, 2025 at 2:06 AM
glomerican.bsky.social
Hap-Pee Halloween Friends !! #kidneyjokes #kidneypuns #halloween2025
October 27, 2025 at 8:59 PM
Reposted by Janany S
nephjc.bsky.social
⏩ Next #NephJC is on IgA nephropathy @kdigo.org guideline

🎨 Nice visual summary by @roxnonna23.bsky.social

www.nephjc.com/news/2025/10...
KDIGO 2025 IgA guidelines - Visual Abstract — NephJC
KDIGO 2025 is here. IgAN management is evolving with precision risk tools, new therapies, and a stronger focus on kidney protection. Check out the visual abstract created by Natalia Nombera
www.nephjc.com
October 27, 2025 at 5:27 PM
Reposted by Janany S
nephjc.bsky.social
1/10
Last #NephJC we tried to answer the question whether protein supplementation increases health related QoL 🥩💊#TenPostNephJC .
Read the article 👇
pubmed.ncbi.nlm.nih....
October 22, 2025 at 9:05 AM
Reposted by Janany S
edgarvlermamd.bsky.social
Decision support for PICC Line placement in patients with CKD ca. 2023
#Nephpearls #VascularAccessPearls #NephSky

#VisualGraphic by @brianrifkin.bsky.social

👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/
September 29, 2025 at 8:04 PM
Reposted by Janany S
nephjc.bsky.social
Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘.
Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC
www.nephjc.com/news/chimera-tolerance-njqe334
Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression? — NephJC
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
www.nephjc.com
September 29, 2025 at 1:56 AM
Reposted by Janany S
nephjc.bsky.social
It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
www.nephjc.com
September 22, 2025 at 12:47 AM
Reposted by Janany S
glomcon.org
#GlomConHawaii 2025 🌴🌊 session: EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement

Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon
July 28, 2025 at 6:57 PM
Reposted by Janany S
nephjc.bsky.social
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
www.nephjc.com
September 16, 2025 at 11:47 AM
Reposted by Janany S
hswapnil.medsky.social
Agree with this algorithm from evidence.nejm.org/doi/full/10.... ($$$ or sub reqd)

Flozinate and Glipinate

Metformin only if these are not appropriate or possible

All else comes later
Algorithm for management of diabetes with flozins and GLP1RAs as mainstay
September 16, 2025 at 1:45 PM
Reposted by Janany S
brianrifkin.bsky.social
Join us #NephJC #NephSky
September 1, 2025 at 10:51 PM
Reposted by Janany S
nephjc.bsky.social
Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social

www.nephjc.com/news/2025/8/...
The ACHIEVE visual abstract — NephJC
the use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial.
www.nephjc.com
September 1, 2025 at 10:50 PM
Reposted by Janany S
nephjc.bsky.social
T0b
Expert opinion—not RCTs—has dominated guidelines on phosphorus control in ESRD for decades. Why? Because phosphate feels like a villain... but is it really? 🦹‍♂️ I can feel it in my bones. #NephJC
August 6, 2025 at 1:10 AM
Reposted by Janany S
nephjc.bsky.social
Check the insightful #NephJC summary by Akshaya Jayachandran ‪@nephromommy-akshu.bsky.social, Natalia Nombera @roxnonna23.bsky.social, Janany Sabescumar @glomerican.bsky.social

www.nephjc.com/news/...
July 23, 2025 at 1:05 AM
Reposted by Janany S
nephjc.bsky.social
On 7/22/25 at 9pm EST only on Bluesky!
#NephSky #MedSky join us for a lively discussion.
We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC
www.nephjc.com/news/egfrdiff
Mind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJC
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
www.nephjc.com
July 21, 2025 at 11:31 AM
Reposted by Janany S
alunieczka.bsky.social
As always the @nephjc.bsky.social summer book turns out to be a great and fascinating read. Highly recommended.
July 6, 2025 at 6:38 AM
Reposted by Janany S
nephjc.bsky.social
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social

⏰Chat happening on July 8, 9 pm EST

www.nephjc.com/news/2025/7/...
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
www.nephjc.com
July 7, 2025 at 8:00 PM
Reposted by Janany S
nephjc.bsky.social
1/10
Last #NephJC we discussed tacrolimus (TAC) versus mycophenolate mofetil (MMF) for the treatment of pediatric nephrotic syndrome. A first👶to👶immunosuppression study for SSNS in kids #TenPostNephJC .
Read the articles 👇
pmc.ncbi.nlm.nih.gov/articles/PMC...
June 25, 2025 at 3:10 PM
Reposted by Janany S
hswapnil.medsky.social
The class of 2025, #NephJC interns

www.nephjc.com/news/2025/6/...
NephJC interns
June 21, 2025 at 2:04 PM
glomerican.bsky.social
Another year another group of fellows leave the nest! Congratulations Annuj and Mumin!
June 17, 2025 at 11:21 AM
Reposted by Janany S
nephjc.bsky.social
Major Trials in the use of ASIs targeting difficult-to-control hypertension #NephJC
May 28, 2025 at 1:46 AM
Reposted by Janany S
stephanietr612.bsky.social
NephJC Internship 2025 Kick-Off! Let's do this!! @nephjc.bsky.social
June 15, 2025 at 1:22 AM
glomerican.bsky.social
First collaborative Nephrology/Endocrinology Shark Tank, so proud of our fellows and thanks to our panelist of expert judges!
May 21, 2025 at 7:12 PM